BIOC - Biocept, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 4/9/2020
Current
12/31/20199/30/20196/30/20193/31/2019
Market Cap (intraday) 5
30.33M15.66M18.70M20.94M21.64M
Enterprise Value 3
23.57M12.25M9.41M9.66M18.22M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.040.902.141.530.99
Price/Book (mrq)
2.712.031.431.827.13
Enterprise Value/Revenue 3
4.266.876.158.1117.79
Enterprise Value/EBITDA 6
-1.06-3.38-1.73-1.28-3.21

Trading Information

Stock Price History

Beta (5Y Monthly) 0.08
52-Week Change 3-65.71%
S&P500 52-Week Change 3-4.04%
52 Week High 32.1100
52 Week Low 30.2100
50-Day Moving Average 30.3403
200-Day Moving Average 30.4670

Share Statistics

Avg Vol (3 month) 313.14M
Avg Vol (10 day) 310.68M
Shares Outstanding 5108.71M
Float 99.69M
% Held by Insiders 10.04%
% Held by Institutions 19.61%
Shares Short (Mar 12, 2020) 4485.01k
Short Ratio (Mar 12, 2020) 40.02
Short % of Float (Mar 12, 2020) 42.57%
Short % of Shares Outstanding (Mar 12, 2020) 40.52%
Shares Short (prior month Feb 13, 2020) 4835.27k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Jul 09, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-417.05%

Management Effectiveness

Return on Assets (ttm)-108.83%
Return on Equity (ttm)-352.98%

Income Statement

Revenue (ttm)5.53M
Revenue Per Share (ttm)0.27
Quarterly Revenue Growth (yoy)107.50%
Gross Profit (ttm)-5.45M
EBITDA -22.13M
Net Income Avi to Common (ttm)-25.26M
Diluted EPS (ttm)-1.2230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.3M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)2.54M
Total Debt/Equity (mrq)22.68
Current Ratio (mrq)2.50
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-23.05M
Levered Free Cash Flow (ttm)-15.48M